
Contact us
About company
Developer of first-in-class lysin-based antimicrobial therapeutics. The company's antimicrobial therapeutics offers a treatment for skin infections caused by multi-drug resistant acinetobacter baumanii.
Unknown
Unknown
Unknown
Not verified company